Skip to search formSkip to main contentSkip to account menu

SB 219383

Known as: N-tyrosyl-2-amino(2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo(3.2.1)oct-3-yl)acetic acid, SB-219383 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Bridged Bicyclo Compounds, HeterocyclicFurans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Synthesis and Activity of Analogues of SB-219383 : Novel Potent Inhibitors of Bacterial Tyrosyl tRNASynthetase
SB-219383 is a naturally occurring antibiotic, which acts by inhibition of tyrosyl tRNA synthetase. Semi-synthetic derivatives of… 
2002
2002
Confirmation of the antibacterial mode of action of SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp.
The compound designated SB-219383 is a potent and selective inhibitor of bacterial tyrosyl tRNA synthetases. It exhibits an IC50… 
2001
2001
Synthetic analogues of SB-219383. Novel C-glycosyl peptides as inhibitors of tyrosyl tRNA synthetase.
2000
2000
SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp. II. Structure determination.
A novel tyrosyl tRNA synthetase inhibitor, SB-219383, has been isolated from a Micromonospora sp. The structure of SB-219383 has… 
2000
2000
Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of four stereoisomeric analogues of the natural product SB-219383.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)